Alopecia is the medical term for hair loss of any kind, from any cause, on any part of the body. It is not one disease but a broad category that covers dozens of distinct conditions ranging from the gradual thinning most people associate with aging to sudden, patchy loss driven by the immune system to permanent destruction of hair follicles by scarring. Understanding what “alopecia” actually means matters because the word gets thrown around as though it names a single problem, when in reality the type of alopecia determines everything from whether the hair can regrow to which treatments are worth trying.
The Hair Cycle and Why It Matters
Hair follicles do not produce hair continuously. Each follicle cycles through phases of active growth, regression, rest, and shedding. The growth phase is when the follicle is producing a visible hair shaft, and it can last several years on the scalp. The regression phase is a short transition period, and the resting phase follows, after which the hair is released and a new cycle begins.1PubMed Central. A Guide to Studying Human Hair Follicle Cycling In Vivo At any given time, roughly 9% of your scalp follicles are in the resting phase, which is why you shed some hair every day without noticing thinning.2PubMed Central. Integrative and Mechanistic Approach to the Hair Growth Cycle and Hair Loss
Alopecia, broadly speaking, happens when something disrupts this cycle. Inflammation, hormones, stress, nutritional deficiencies, poor sleep, and certain medications can all push follicles out of the growth phase prematurely.3PubMed Central. Integrative and Mechanistic Approach to the Hair Growth Cycle and Hair Loss The nature and severity of that disruption is what separates one type of alopecia from another.
Non-Scarring Alopecia
The most important distinction in hair loss is between non-scarring and scarring types. In non-scarring alopecia, the follicle itself remains intact even though hair production has slowed or stopped. That preservation means regrowth is at least theoretically possible. Most hair loss that people encounter in everyday life falls into this category.
Androgenetic Alopecia
This is by far the most common form of hair loss worldwide, often called male-pattern or female-pattern hair loss. It is driven by the effects of hormones called androgens on genetically susceptible follicles. A hormone derived from testosterone binds to receptors in the hair follicle, gradually shrinking the follicle over successive growth cycles so that it produces thinner, shorter, less visible hairs.4PubMed. Androgenetic alopecia: a review Animal studies have confirmed that this hormone induces early regression of the hair cycle, reduced hair density, and changes in hair structure, and that blocking the androgen receptor can partly reverse these effects.5PubMed. Dihydrotestosterone-induced hair regrowth inhibition by activating androgen receptor in C57BL6 mice simulates androgenetic alopecia
In men, the pattern typically begins at the temples and crown. In women, it usually presents as diffuse thinning over the top of the scalp while the frontal hairline is preserved. Despite its reputation as a simple “genetic” condition, genome-wide research now shows that androgenetic alopecia is a complex disorder involving many gene regions and multiple biological pathways beyond androgen signaling alone, including hair follicle development, cell survival, and the structural scaffolding around follicles.6PubMed Central. The Genetic Landscape of Androgenetic Alopecia: Current Knowledge and Future Perspectives
Alopecia Areata
Alopecia areata is an autoimmune condition in which the body’s own immune cells attack hair follicles. Hair follicles normally enjoy a degree of protection from immune surveillance, but when that protection breaks down, immune cells infiltrate the follicle and shut down hair production.7PubMed Central. Immune Privilege Collapse and Alopecia Development: Is Stress a Factor The result is usually one or more round, smooth patches of complete hair loss on the scalp, though it can affect beards, eyebrows, and body hair too. In more severe forms, it can progress to total scalp hair loss or loss of all body hair.
A UK cohort study estimated the lifetime incidence of alopecia areata at about 2%, with women affected slightly more often than men.8British Journal of Dermatology. Lifetime incidence and healthcare disparities in alopecia areata: a UK population-based cohort study A US study found the highest prevalence among Asian patients, followed by Black and Hispanic or Latino patients, with White patients having the lowest prevalence.9PubMed Central. Overall and Racial and Ethnic Subgroup Prevalences of Alopecia Areata, Alopecia Totalis, and Alopecia Universalis Global modeling studies have confirmed that the condition is most prevalent in Asian populations and that adults between roughly 19 and 50 years old are the most commonly affected age group.10British Journal of Dermatology. Global, regional and national epidemiology of alopecia areata: a systematic review and modelling study
Telogen Effluvium
Telogen effluvium is a diffuse, often sudden shedding of hair that occurs when a large number of follicles are pushed into the resting phase at the same time. Common triggers include physical trauma, surgery, high fever, emotional stress, crash dieting, and certain medications.11PubMed Central. Telogen Effluvium: A Review of the Literature The shedding typically appears two to three months after the triggering event, which is why people often fail to connect the cause with the effect.
Research into the stress-hair connection has fleshed out how this works at a hormonal level. Stress hormones can inhibit hair shaft growth and push follicles into the regression phase by binding to receptors on follicular cells. Elevated cortisol degrades the structural components that keep follicles healthy, and stress-related neuropeptides cause inflammation around the follicle and damage to the cells that build hair.12CosmoDerma. Hypothalamic-pituitary-adrenal axis, hair, and sebum: Stress-mediated dermatologic disasters of the pandemic era The good news is that telogen effluvium is almost always self-limiting; once the trigger is removed, hair typically regrows within several months.
Traction Alopecia
Traction alopecia results from sustained pulling force on the hair, usually from tight hairstyles such as braids, ponytails, extensions, or weaves. Early on, the condition looks like telogen effluvium caused by mechanical stress, and it is fully reversible if the tension is relieved. But if the pulling continues over repeated cycles without adequate rest periods, the tissue around the follicle develops scarring, and the hair loss becomes permanent.13Journal of Craniofacial Surgery Open. Hair Extensions: Anatomic, Biological, and Clinical Implications in Alopecia This makes traction alopecia unusual in that it straddles the line between non-scarring and scarring hair loss depending on how long the damage has been occurring.
Scarring (Cicatricial) Alopecia
In scarring alopecias, the hair follicle itself is destroyed and replaced by scar tissue, making regrowth impossible in affected areas. This destruction can happen because the follicle is the direct target of a disease process, or because the follicle gets caught up as an “innocent bystander” in a broader skin disease happening around it.14PubMed. Cicatricial (scarring) alopecias: an overview of pathogenesis, classification, diagnosis, and treatment Some conditions that start as non-scarring can even transition to scarring in their later stages.
Primary scarring alopecias are classified by the type of inflammatory cells doing the damage. Lymphocyte-driven forms include lichen planopilaris and frontal fibrosing alopecia, conditions in which immune cells cluster around the upper part of the follicle and progressively destroy it. Frontal fibrosing alopecia is considered a variant of lichen planopilaris because the tissue findings are similar, though the clinical pattern differs: it typically presents as a slowly receding hairline at the front and sides of the scalp, often with loss of eyebrow hair.15PubMed Central. Lichen planopilaris and frontal fibrosing alopecia: review and update of diagnostic and therapeutic features Other forms are driven by neutrophils or by a mix of inflammatory cell types.16PubMed. Primary cicatricial alopecia: Lymphocytic primary cicatricial alopecias, including chronic cutaneous lupus erythematosus, lichen planopilaris, frontal fibrosing alopecia, and Graham-Little syndrome
Scarring alopecias are rarer than androgenetic alopecia or alopecia areata, but they carry greater urgency. Because the damage is irreversible once scarring sets in, early diagnosis and treatment to halt progression are critical.
Chemotherapy-Related Hair Loss
Hair loss from cancer treatment is a distinct phenomenon. Chemotherapy drugs target rapidly dividing cells, and hair follicle cells in the active growth phase are among the fastest-dividing cells in the body. When these drugs trigger cell death in the follicle, the result is widespread shedding that often begins within weeks of starting treatment.17PubMed Central. Molecular mechanisms of chemotherapy-induced hair loss Unlike telogen effluvium, where resting hairs are shed, chemotherapy-induced loss attacks hairs that are actively growing. Hair usually regrows after treatment ends, though the texture and color sometimes change temporarily.
How Alopecia Is Diagnosed
Diagnosis begins with a thorough history and physical examination. When did the loss start? Is it patchy or diffuse? Is there a family history? Are there signs of inflammation, scarring, or broken hairs? These questions already narrow the possibilities considerably.18PubMed. Common causes of hair loss – clinical manifestations, trichoscopy and therapy
A key tool is trichoscopy, which is essentially using a magnifying device to examine the scalp and hair shafts at close range. It is simple, painless, and can reveal patterns invisible to the naked eye: miniaturized hairs suggesting androgenetic alopecia, “exclamation point” hairs characteristic of alopecia areata, or perifollicular scaling in scarring conditions. Trichoscopy can often make a biopsy unnecessary, though when scarring alopecia is suspected or the diagnosis is uncertain, a small scalp biopsy remains the definitive test.19PubMed Central. Trichoscopy in alopecias: diagnosis simplified Laboratory tests like bloodwork are often unnecessary unless an underlying systemic cause such as thyroid disease or iron deficiency is suspected.20PubMed. Common causes of hair loss – clinical manifestations, trichoscopy and therapy
That said, the evidence linking common nutritional markers to hair loss is thinner than many people assume. One study of men with pattern hair loss found no significant difference in iron stores or thyroid hormone levels compared to men without hair loss.21PubMed Central. A Study of Serum Ferritin and Thyroid-Stimulating Hormone Levels in Male Patients with Androgenetic Alopecia A separate study of patients with scarring alopecias found no significant differences in vitamin D, vitamin B12, folate, ferritin, or thyroid function compared to healthy controls.22PubMed. Micronutrient levels and thyroid functions in scarring alopecias: Do they play a role in disease pathogenesis? Screening for these deficiencies is still reasonable in clinical practice, but blanket supplementation for hair loss without a confirmed deficiency is not well supported.
Treatment Options
What can be done about alopecia depends entirely on the type. There is no single treatment for “alopecia” because the underlying causes are so different.
Androgenetic Alopecia
A meta-analysis comparing the main medical treatments for male pattern hair loss ranked them by effectiveness. Oral dutasteride at a low daily dose had the highest probability of being the most effective option, followed in order by oral finasteride at higher doses, oral minoxidil, oral finasteride at standard doses, and topical minoxidil formulations.23JAMA Dermatology. Relative Efficacy of Minoxidil and the 5-α Reductase Inhibitors in Androgenetic Alopecia Treatment of Male Patients Dutasteride and finasteride work by blocking the enzyme that converts testosterone into the more potent androgen that shrinks follicles; dutasteride blocks more of that enzyme, which is why it tends to suppress the harmful hormone more effectively.24PubMed. Comparison of oral minoxidil, finasteride, and dutasteride for treating androgenetic alopecia Minoxidil promotes growth through a different set of mechanisms, including increasing blood flow and stimulating growth-signaling pathways. For women, minoxidil is the best-supported option; a separate meta-analysis confirmed its effectiveness for female pattern hair loss as well.25PubMed. The effectiveness of treatments for androgenetic alopecia: A systematic review and meta-analysis
Low-level laser light therapy and microneedling have also shown promise as additional tools. Devices such as LED helmets are being studied in combination with microneedling patches to deliver light energy closer to the follicle.26PubMed. The efficacy of light-guiding microneedle patch for stimulating hair growth in androgenetic alopecia For advanced cases, hair transplantation remains the definitive surgical option, and early evidence suggests that platelet-rich plasma injections at the time of transplantation may improve graft survival and density, though large-scale trials with standardized methods are still needed.27PubMed Central. Efficacy of Platelet-Rich Plasma as an Adjunct to Hair Transplantation: A Systematic Review
Alopecia Areata
Treating alopecia areata has historically been frustrating because the condition is unpredictable: some patches regrow spontaneously, while severe cases resist everything. The landscape changed meaningfully with the development of JAK inhibitors, a class of drugs that target specific immune-signaling pathways. These medications can promote the reactivation of dormant follicle stem cells, and studies have shown good effectiveness with relatively few serious side effects.28PubMed Central. Janus kinase inhibitors for alopecia areata: a review of clinical data The approach grew from the repurposing of JAK inhibitors already approved for other conditions, where researchers demonstrated they could effectively reverse hair loss in patients with moderate to severe alopecia areata.29PubMed Central. JAK Inhibitors for Treatment of Alopecia Areata Several JAK inhibitors are now approved specifically for alopecia areata in multiple countries, which represents a genuine shift in how the condition is managed.
The Psychological Weight of Hair Loss
Alopecia is frequently dismissed as a cosmetic issue, but the psychological burden is real and well-documented. People experiencing hair loss commonly report self-consciousness, embarrassment, frustration, and jealousy toward those with full hair. Even perceived thinning that has not progressed to visible loss can affect someone’s sense of self.30PubMed Central. Psychology of Hair Loss Patients and Importance of Counseling
The associations go deeper than mood. Depending on the type and geographic population studied, alopecia has been linked to higher rates of anxiety, depression, and even suicidal thoughts, as well as medical conditions including thyroid disease, diabetes, and autoimmune disorders. Quality-of-life scores drop across multiple measures in patients with hair loss.31PubMed. The Medical and Psychosocial Associations of Alopecia: Recognizing Hair Loss as More Than a Cosmetic Concern The UK alopecia areata study found that disparities in psychological impact also vary by demographic group: Black patients with alopecia areata had the highest rates of both anxiety and time off work compared to matched controls.32British Journal of Dermatology. Lifetime incidence and healthcare disparities in alopecia areata: a UK population-based cohort study Framing alopecia purely as an appearance issue sells short what is, for many people, a meaningful medical and emotional burden.
Trichotillomania and Behavioral Hair Loss
Not all hair loss has a medical cause in the traditional sense. Trichotillomania is a condition in which a person repeatedly pulls out their own hair, often without full awareness of doing so. It is classified as a body-focused repetitive behavior and is distinct from other alopecias in that the follicle is undamaged until the mechanical pulling itself causes inflammation or scarring over time. In one study of children presenting with hair loss, about 7% had trichotillomania. The average age of onset was around 10 years old, and it was more common in girls. Examination revealed broken hairs of varying lengths in a circular pattern, with otherwise normal-looking scalp skin. In some cases, involvement extended beyond the scalp to include the eyebrows.33PubMed Central. Hair Loss in Children: Common and Uncommon Causes; Clinical and Epidemiological Study in Jordan Treatment for trichotillomania is behavioral and sometimes pharmaceutical, not dermatological, which is why recognizing the pattern matters for avoiding inappropriate treatment.
The Scalp Microbiome Connection
An emerging area of research is the relationship between the microbial communities living on and around the scalp and various forms of hair loss. Evidence now links changes in the scalp, hair follicle, and even gut microbiome to multiple types of alopecia.34PubMed Central. The Gut and Skin Microbiome in Alopecia: Associations and Interventions In androgenetic alopecia specifically, researchers using advanced sequencing of bacterial and fungal communities have found that microbial imbalance is not confined to the balding area but extends across the entire scalp, and the severity of the imbalance tracks with the severity of hair loss.35PubMed Central. Microbial dysbiosis and its diagnostic potential in androgenetic alopecia: insights from multi-kingdom sequencing and machine learning
A recent review attempted to pull together what is known across alopecia subtypes. Shared features of disrupted scalp microbial communities include impaired skin barrier function, activation of the innate immune system, and altered metabolism of fats and other molecules that support hair growth. On top of these shared patterns, each type of alopecia has its own characteristic microbial signatures: immune-privilege breakdown in alopecia areata, coupling between androgens, scalp lipids, and bacteria in androgenetic alopecia, and overgrowth of specific fungi in seborrheic dermatitis-related shedding.36PubMed Central. The Scalp Microbiome-Hair Axis: Mechanisms and Therapeutic Translation This is still largely at the stage of describing patterns rather than offering treatments, but the direction is clear enough that microbiome-targeted therapies for hair loss are an active area of development.
Why Male Pattern Hair Loss Persists in the Gene Pool
If androgenetic alopecia is partly genetic and so widespread, a fair question is why evolution has not eliminated it. One hypothesis proposes that male pattern hair loss may have actually served a function in our evolutionary past by acting as a visible signal of age. Because conceptions by younger fathers are more likely to result in live births and because children of younger fathers tend to have fewer health complications, there may have been selective pressure for women to favor younger-looking mates. Hair loss that became visible in a man’s thirties or forties could have served as an honest cue of age, nudging mate selection toward younger partners whose offspring would be healthier.37PubMed. Male pattern hair loss: Taking one for the team: The selfless gene The idea is speculative, but it offers a framework for understanding why such a common trait might benefit a population even while disadvantaging the individual who carries it.